AstraZeneca PLC to sell type 2 drug in Japan

AstraZeneca PLC and Bristol-Myers Squibb Co. announced plan to extend in Japan. The pharmaceutical companies aims to sell type 2 diabetes drug called dapagliflozin in Japan.

The diabetes drug dapagliflozin, is a once daily drug. It is hoping to gain permission from health authorities in those countries to sell the drug in 2012.The companies said it was still too early to say when the drug might hit pharmacy shelves in Japan.

AstraZeneca’s shares rose 5 percent to 2,686 pence ($39.91) in London.

Source: AP

Filed under Diabetes, Diabetes Drug, NIDDM | Tags: , , , , | 1 Comment

Related?

One Response to “AstraZeneca PLC to sell type 2 drug in Japan”

  1. uwak Says:

    what is the type of drugs? new formula or just new packaging?

Leave a Reply


Protected by Comment Guard Pro